Clinical Trial to Reconfirm the Efficacy and Safety of Cefetamet Pivoxil Treatment in Sinusitis Patients: A Double-Blind, Randomized, Parallel Designed, Multicenter, Active Comparator Study (CASIS Study).

Chan-Soon ParkJin Hee ChoHeung-Man LeeKyung-Su KimJin Kook KimDong-Young KimByoung Joon BaekHyun Jun KimYong-Dae KimChi Sang HwangSeon Tae KimSeok Hyun ChoYong Min KimSeung Hoon LeeJin Hyeok JeongSeung Min InByung Guk Kim

Published in: Ear, nose, & throat journal (2021)

Cefetamet pivoxil twice a day was as efficacious and safe as cefdinir 3 times a day for the treatment of acute bacterial rhinosinusitis, which suggested that cefetamet pivoxil may be a suitable alternative to cefdinir.

Keyphrases

clinical trial
double blind
end stage renal disease
open label
ejection fraction
randomized controlled trial
phase iii
peritoneal dialysis
prognostic factors
study protocol
patient reported